Company Analysis

Immunocore Holdings plc (IMCR)

Nasdaq: IMCR · Biological Products, (No Diagnostic Substances) · Oxfordshire, GB · filing with the SEC since 2016
Grade6.7
◀ Past 7.3● Present 6.6▶ Future 6.1
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

45 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Immunocore Holdings plc’s names, not what it holds today.

Patents granted
45
45 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 5 in 2024 and 5 in 2023
Applications published
133
10 of them in 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology8
Pharmaceuticals6
Computer technology2
Organic fine chemistry2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
IMMUNOCORE LIMITED a former name
named as the applicant on its applications, in GB
0 granted
116 published
IMMUNOCORE LIMITED a former name
GB, as the owner printed on each patent
45 granted
17 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jan 14, 202512,195,534Binding moleculesBiotechnologyIMMUNOCORE LIMITED
Nov 5, 202412,134,647Binding moleculesBiotechnologyIMMUNOCORE LIMITED
Oct 1, 202412,103,971HIV specific binding moleculesBiotechnologyIMMUNOCORE LIMITED
Aug 20, 202412,065,475T cell receptors and fusion proteins thereofBiotechnologyIMMUNOCORE LIMITED
Jun 25, 202412,018,062T cell receptorsPharmaceuticalsIMMUNOCORE LIMITED
Mar 12, 202411,929,151Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complexComputer technologyIMMUNOCORE LIMITED
Nov 28, 202311,827,688Dosing regimen for GP100-specific TCR-anti-CD3 SCFV fusion proteinBiotechnologyIMMUNOCORE LIMITED
Aug 29, 202311,739,442TCR librariesOrganic fine chemistryIMMUNOCORE LIMITED
Aug 29, 202311,739,441TCR librariesBiotechnologyIMMUNOCORE LIMITED
Aug 8, 202311,718,657T cell receptorsPharmaceuticalsIMMUNOCORE LIMITED
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 4, 20252025/0367285METHODS OF TREATING MELANOMA USING TEBENTAFUSP AND IMMUNE CHECKPOINT INHIBITORSPharmaceuticalsIMMUNOCORE LIMITED
Oct 30, 20252025/0333513MULTI-DOMAIN MOLECULESBiotechnologyIMMUNOCORE LIMITED
Oct 30, 20252025/0333504TREATMENTPharmaceuticalsIMMUNOCORE LIMITED
Oct 2, 20252025/0304652HALF-LIFE EXTENDED IMMTAC BINDING CD3 AND A HLA-A*02 RESTRICTED PEPTIDEBiotechnologyIMMUNOCORE LIMITED
Aug 28, 20252025/0270327SPECIFIC BINDING MOLECULESBiotechnologyIMMUNOCORE LIMITED
Jul 31, 20252025/0243275MULTI-DOMAIN BINDING MOLECULESPharmaceuticalsIMMUNOCORE LIMITED
Jun 5, 20252025/0179178BINDING MOLECULESBiotechnologyIMMUNOCORE LIMITED
May 1, 20252025/0134956PEPTIDES DERIVED FROM KITA-KYUSHU LUNG CANCER ANTIGEN (KKLC1, CT83, CXORF61) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULESPharmaceuticalsIMMUNOCORE LIMITED
Apr 24, 20252025/0129161HIV Specific Binding Molecules and Uses ThereofPharmaceuticalsIMMUNOCORE LIMITED
Jan 23, 20252025/0026829BINDING MOLECULESBiotechnologyIMMUNOCORE LIMITED
What it applied for, 2024 to 2025: Biotechnology 10 · Pharmaceuticals 8 · Computer technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton IMCR · research, not advice